Description  Claims  Drawing  Cited references 

US5370879A   [0015]  [0071] 
US5540938A   [0015]  [0071] 
US8007826B   [0015]  [0015]  [0071] 
US20050228030A   [0015]  [0015]  [0071] 
WO8909600A   [0017] 
US20020022587A1   [0017] 
WO02064126A2   [0017] 
US5952357A   [0054] 
US20050276851   [0075] 
US20050228030   [0075] 

Circulation   [0003] 
Expert Rev Neurother.   [0006] 
J Cereb Blood Flow Metab.   [0011] 
Behav Brain Res.   [0011] 
Stroke   [0011] 
Neuropharmacology   [0011] 
Cell Death Differ.   [0012] 
Int J Mol Med.   [0012] 
Stroke   [0017] 
European Journal of Pharmacology   [0017] 
Pharmaceutical Salts   [0043]  [0057] 
No To Shinkei   [0147] 
Ann Neurol   [0148] 
Brain Res   [0160] 
J. Neurosci   [0161] 
J. Clin. Pharmacol.   [0180] 
Spinal Cord   [0180] 
Administration and Scoring Manual published by the National Multiple Sclerosis Society   [0275] 
Age and Ageing.   [0276]  [0277] 
Am J Occup Ther.   [0277] 
Arch Phys Med Rehabil.   [0279]  [0280]  [0282] 
Scand J Rehabil Med.   [0283] 
Arch Phys Med Rehabil.   [0286] 
Acute stroke management and prevention of recurrences. In Evidence-Based Neurology   [0331] 
US cost burden of ischemic stroke: A systematic review   [0331] 
Heart Disease and Stroke Statistics-2008 Update   [0331] 
Heart Disease and Stroke Statistics 2009 Update: A Report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee   [0331] 
Disability status at one month is a reliable proxy for final ischemic stroke outcome   [0331] 
Quality of Life among Stroke survivors evaluated 1 year after Stroke   [0331] 
Understanding motor impairment in the paretic lower limb after Stroke: A review of the literature   [0331] 
Neuroplasticity in the context of motor rehabilitation after stroke   [0331] 
Exercise-mediated locomotor recovery and lower-limb neuroplasticity after stroke   [0331] 
Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10171 in acute stroke treatment   [0331] 
Guidelines for the early management of adults with ischemic stroke: A guideline from the American Heart Association/American Sroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in research Interdisciplinary Working Groups   [0331] 
Imaging Evaluation of Acute Ischemic Stroke   [0331] 
Lifetime cost of stroke in the United States   [0331] 
Dose comparison trial of sustained-release fampridine in multiple sclerosis   [0331] 
Sustained-release oral fampridine in multiple sclerosis: a randomized, double-blind, controlled trial   [0331] 
A Phase 2 trial of extended release oral dalfmapridine in multiple sclerosis   [0331] 
Ischaemic stroke in adults and epilepsy   [0331] 
Prevalence and predictors of early seizure and status epilepticus after first stroke   [0331] 
A practical review and approach to poststroke seizures   [0331] 
Seizures after stroke: A prospective multicenter study   [0331] 
Incidence of seizures in the acute phase of stroke: A population-based study   [0331] 
Predictors of acute post-stroke seizures   [0331] 
Potassium channel blockers attenuate hypoxia and ischemia-induced neuronal death in vitro and in vivo   [0331] 
Potassium channel blocker TEA prevents CA1 hippocampal injury following transient forebrain ischemia in adult rats   [0331] 
Slowly inactivating potassium conductance (ID): A potential target for stroke therapy   [0331] 
The Multiple Sclerosis Functional Composite Administration and Scoring Manual   [0331] 
Comfortable and maximum walking speed of adults aged 20-79 years: reference values and determinants   [0331] 
Adult norms for the Box and Block Test of manual dexterity   [0331] 
Grip and pinch strength; normative data for adults   [0331] 
The post-stroke hemiplegic patient: a method for evaluation of physical performance   [0331] 
Code of Federal Regulations, Title 21 Food and Drugs. In: Selected Regulations and Guidance for Drug Studies. Philadelphia, PA: Clinical Research Resources   [0331] 
World Medical Association. Declaration of Helsinski   [0331] 
Inter-and intrarater reliability of the Ashworth Scale and the Disability Assessment Scale in patients with upper-limb poststroke spasticity   [0331] 
Heart disease and stroke statistics--2012 update: a report from the American Heart Association   [0363] 
The alterations of oligodendrocyte, myelin in corpus callosum, and cognitive dysfunction following chronic cerebral ischemia in rats   [0363] 
Preferential loss of myelin-associated glycoprotein reflects hypoxia-like white matter damage in stroke and inflammatory brain diseases   [0363] 
Is white matter involved in patients entered into typical trials of neuroprotection   [0363] 
Structural integrity of corticospinal motor fibers predicts motor impairment in chronic stroke   [0363] 
Cerebral white matter hyperintensities predict functional stroke outcome   [0363] 
Cerebral white matter is highly vulnerable to ischemia   [0363] 
The axon: structure, function, and pathophysiology   [0363] 
Ion channels and neuronal dysfunction in multiple sclerosis   [0363] 
Mechanisms of axonal dysfunction after spinal cord injury: with an emphasis on the role of voltage-gated potassium channels   [0363] 
Changes in axonal physiology and morphology after chronic compressive injury of the rat thoracic spinal cord   [0363] 
4-Aminopyridine leads to restoration of conduction in demyelinated rat sciatic nerve   [0363] 
Effects of 4-aminopyridine on normal and demyelinated mammalian nerve fibres   [0363] 
The effects of 4-aminopyridine and tetraethylammonium ions on normal and demyelinated mammalian nerve fibres   [0363] 
Differential effects of low and high concentrations of 4-aminopyridine on axonal conduction in normal and injured spinal cord   [0363] 
Effects of 4-aminopyridine on stretched mammalian spinal cord: the role of potassium channels in axonal conduction   [0363] 
Effect of 4-aminopyridine on axonal conduction-block in chronic spinal cord injury   [0363] 
The use of 4-aminopyridine (fampridine) in demyelinating disorders   [0363] 
Phase 2 trial of sustained-release fampridine in chronic spinal cord injury   [0363] 
Dose comparison trial of sustained-release fampridine in multiple sclerosis   [0363] 
A phase 3 trial of extended release oral dalfampridine in multiple sclerosis   [0363] 
Dalfampridine (Ampyra) for multiple sclerosis   [0363] 
Guide to the care and use of laboratory animals   [0363] 
Focal cerebral infarction in the rat: I. Operative technique and physiological monitorings for chronic model   [0363] 
Neocortical localization of tactile/proprioceptive limb placing reactions in the rat   [0363] 
vated body swing test: a new behavioral parameter for rats with 6-hydroxydopamine-induced hemiparkinsonism   [0363] 
Repairing the human brain after stroke: I. Mechanisms of spontaneous recovery   [0363] 
Oligodendrocytes and ischemic brain injury   [0363] 
Selective glial vulnerability following transient global ischemia in rat brain   [0363] 
Demyelination in spinal cord injury and multiple sclerosis: what can we do to enhance functional recovery   [0363] 
Enhancement of action potential conduction following demyelination: experimental approaches to restoration of function in multiple sclerosis and spinal cord injury   [0363] 
Neuropathology of human spinal cord injury sustained in sports-related activities   [0363] 
A review of the neuropathology of human spinal cord injury with emphasis on special features   [0363] 
opyridines potentiate synaptic and neuromuscular transmission by targeting the voltage-activated calcium channel beta subunit   [0363] 
The effects of 4-aminopyridine on neurological deficits in chronic cases of traumatic spinal cord injury in dogs: a phase I clinical trial   [0363] 
Dalfampridine in multiple sclerosis   [0363] 
Pharmacokinetics of an immediate-release oral formulation of Fampridine (4-aminopyridine) in normal subjects and patients with spinal cord injury   [0363] 
Intravenous infusion of 4-AP in chronic spinal cord injured subjects   [0363] 
Motor cortex bilateral motor representation depends on subcortical and interhemispheric interactions   [0363] 
A functional MRI study of subjects recovered from hemiparetic stroke   [0363] 
Functional magnetic resonance imaging of reorganization in rat brain after stroke   [0363]